Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Change in Account Payables came in at $275000.0 in Q3 2025, up 587.5% year-over-year from $40000.0 in Q3 2024, and up 170.15% quarter-over-quarter from -$392000.0 in Q2 2025.
Powered by 
Analysis
Vicarious Surgical (RBOT) Change in Account Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Change in Account Payables for 6 consecutive years, with $275000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Change in Account Payables rose 587.5% year-over-year to $275000.0 in Q3 2025; TTM through Sep 2025 was -$495000.0, a 266.67% decrease from a year earlier, with the FY2024 full-year figure at -$96000.0, up 79.7% from the prior year.
- Change in Account Payables was $275000.0 for Q3 2025 at Vicarious Surgical, up from -$392000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.7 million in Q3 2022 and troughed at -$3.3 million in Q4 2022.
- A 5-year average of $22684.2 and a median of $14000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 6748.41% in 2021 and plunged 1135.71% in 2025, its largest moves.
- Over 5 years, Change in Account Payables stood at $937000.0 in 2021, then slumped by 447.71% to -$3.3 million in 2022, then surged by 91.65% to -$272000.0 in 2023, then rose by 14.34% to -$233000.0 in 2024, then jumped by 218.03% to $275000.0 in 2025.
- The last three Change in Account Payables figures came in at $275000.0 (Q3 2025), -$392000.0 (Q2 2025), and -$145000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | -392,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | -951,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Dec 31, 2021 | 937,000.00 |
| Sep 30, 2021 | -346,000.00 |
| Jun 30, 2021 | 492,483.00 |
| Mar 31, 2021 | 43,517.00 |
| Dec 31, 2020 | 13,682.00 |